As a major Canadian centre for amyotrophic lateral sclerosis (ALS) research and treatment, the Montreal Neurological Institute and Hospital - The Neuro, invites the public and the media to learn more about the disease and current research and treatments, to donate money for ALS research and to wear the national emblem of ALS in Canada, the blue cornflower, during ALS Awareness Month in June.
Today the Honourable Ed Holder, Minister of State (Science and Technology) announced an investment of $333 million for research infrastructure through the Canada Foundation for Innovation (CFI). Two projects submitted by researchers affiliated with the Montreal Neurological Institute and Hospital – The Neuro at McGill University and the MUHC, have received a total of over $21 M in funding, with matching funds from the Government of Quebec.
Public lecture: Perspectives on bilingualism: From birth to aging
Living in a city with many languages, we are often confronted with personal debates about what are the best decisions to make for our children and for ourselves. Have you wondered when is the optimal time and in what way to introduce a second language to your child, or whether raising a child in a bilingual environment can create confusion? Have you heard that being bilingual might slow down cognitive decline in aging and provide a buffer against neurodegenerative disease?
The Montreal Neurological Institute and Hospital – The Neuro at McGill University and the MUHC has Canada’s oldest MS clinic but is always innovating - striving for progress and better treatments for patients.
What’s new in MS at The Neuro
An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep disturbances to other behavioral, cognitive, and metabolic abnormalities, commonly associated with jet lag, shift work and exposure to light at night, as well as with neuropsychiatric conditions such as depression and autism.
Secondary Contact Information
Dancing the Argentine tango could have potential benefits for people at certain stages in the development of Parkinson’s disease (PD), according to findings in a new study by researchers at the Montreal Neurological Institute and Hospital -The Neuro, McGill University and the Research Institute of the McGill University Health Centre.
New study puts 40 patients through 12-week course
Dancing the Argentine tango could have potential benefits for people at certain stages in the development of Parkinson’s disease (PD), according to findings in a new study by researchers at the Montreal Neurological Institute and Hospital -The Neuro, McGill University and the Research Institute of the McGill University Health Centre. The study looked at changes in patients’ motor abilities following a 12-week tango course, and is also the first study to assess the effect that tango has on non-motor symptoms.
The Brain@McGill has established this award to recognize the importance of the next generation of promising young neuroscientists in advancing our understanding of the brain. The winner of the Brain@McGill Prize for Neuroscience is awarded $500 and publication in B@M Online and newsletter. The essay and those of the three semi-finalists will also be published in B@M Online.
The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the McGill University Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.
The Neuro to introduce experimental drug treatment
$1 M gift from Mr. J. Sebastian van Berkom launches translational research into neurological disease
A patient’s very own skin cells may hold the key to new treatments and even cures for devastating neurological diseases. A generous $1 million donation from Mr. J. Sebastian van Berkom, and critical partnerships with Brain Canada, Laval University, Marigold Foundation and the FRQS-Réseau Parkinson Quebec are driving an innovative, iPSC (induced pluripotent stem cell) research platform that will transform research into Parkinson’s and other neurological diseases.